I agree that this site is using cookies. You can find further informations here.
X
Bass, Almasa
30  results:
Search for persons X
?
1

Efficacy, safety, and tolerability of adjunctive brivaracet..:

Inoue, Yushi ; Tiamkao, Somsak ; Zhou, Dong...
Epilepsia Open.  9 (2024)  3 - p. 1007-1020 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Heterogeneity of Recent Phase 3 Complicated Urinary Tract I..:

Portsmouth, Simon ; Bass, Almasa ; Echols, Roger.
Open Forum Infectious Diseases.  8 (2021)  3 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
3

Treatment Satisfaction, Anxiety Level, and Confidence About..:

Fakhoury, Toufic ; Chen, Linda ; Bass, Almasa...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
4

Bioequivalence of Ertugliflozin/Sitagliptin Fixed‐Dose Comb..:

Fediuk, Daryl J. ; Matschke, Kyle ; Liang, Yali...
Clinical Pharmacology in Drug Development.  8 (2019)  7 - p. 884-894 , 2019
Link: https://doi.org/10.1002/..
 
?
5

Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combin..:

Dawra, Vikas Kumar ; Liang, Yali ; Wei, Hua...
Clinical Pharmacology in Drug Development.  9 (2019)  1 - p. 50-61 , 2019
Link: https://doi.org/10.1002/..
 
?
6

A PK/PD study comparing twice-daily to once-daily dosing re..:

Dawra, Vikas Kumar ; Liang, Yali ; Shi, Haihong...
Int. Journal of Clinical Pharmacology and Therapeutics.  57 (2019)  4 - p. 207-216 , 2019
Link: https://doi.org/10.5414/..
 
?
7

Effects of intravenous oxycodone alone or in combination wi..:

Bass, Almasa ; Webster, Lynn R. ; Matschke, Kyle T...
Therapeutic Advances in Drug Safety.  10 (2019)  - p. 204209861882127 , 2019
Link: https://doi.org/10.1177/..
 
?
8

Safety and tolerability of ALO-02 (oxycodone hydrochloride ..:

Wilson, Jacquelyn G. ; Bass, Almasa ; Pixton, Glenn C...
Current Medical Research and Opinion.  36 (2019)  1 - p. 91-99 , 2019
Link: https://doi.org/10.1080/..
 
?
9

Effect of Food on the Pharmacokinetics of Ertugliflozin and..:

Sahasrabudhe, Vaishali ; Fediuk, Daryl J. ; Matschke, Kyle...
Clinical Pharmacology in Drug Development.  8 (2018)  5 - p. 619-627 , 2018
Link: https://doi.org/10.1002/..
 
?
10

1521. Heterogeneity of Recent Phase 3 cUTI Clinical Trials ..:

Bass, Almasa ; Echols, Roger ; Portsmouth, Simon.
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S472-S472 , 2018
Link: https://doi.org/10.1093/..
 
?
11

Pharmacokinetics, pharmacodynamics, and safety of bococizum..:

Bass, Almasa ; Plotka, Anna ; Mridha, Khurshid...
Health Science Reports.  1 (2018)  9 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
12

Patient-reported health-related quality of life, work produ..:

Weil, Arnold J. ; Masters, Elizabeth T. ; Barsdorf, Alexandra I....
Health and Quality of Life Outcomes.  15 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
13

Abuse Potential Study of ALO-02 (Extended-Release Oxycodone..:

Setnik, Beatrice ; Bass, Almasa ; Bramson, Candace...
Pain Medicine.  , 2016
Link: https://doi.org/10.1093/..
 
?
14

Intranasal administration of crushed ALO‐02 (extended‐relea..:

Setnik, Beatrice ; Bramson, Candace ; Bass, Almasa...
The Journal of Clinical Pharmacology.  55 (2015)  12 - p. 1351-1361 , 2015
Link: https://doi.org/10.1002/..
 
?
15

Abuse potential study of intravenous oxycodone hydrochlorid..:

Setnik, Beatrice ; Bass, Almasa ; Sommerville, Kenneth W...
Drug and Alcohol Dependence.  146 (2015)  - p. e94 , 2015
Link: https://doi.org/10.1016/..
 
1-15